Retina Clinical Trials
Recruiting retina studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat retina. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting retina studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting retina trials
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes
Feasibility Study of a Remote Behavioral Dietary Intervention in Patients With Early to Intermediate AMD: Glucose Lowering for Vision Extension
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Community-Based Eye Screening With Structured Referral Tracking for Preventing Avoidable Blindness in Adults in Rawalpindi, Pakistan
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Strategies for Improving Linkage-to-Care After Eye Disease Screening
Wide Field OCTA in Ocular Diseases
User-centric Study of Patients' Receptiveness Towards the Web-based Automated Vision Impairment Gaze-tracking Analysis Systems
High Resolution Imaging OCT Study
Multicenter RCT of Eye-Brain Imaging in Diabetes Neurovascular Coupling
A Preliminary Exploratory Clinical Trial to Evaluate the Efficacy of NPDR-01 Eye Drops in the Treatment of Non-Proliferative Diabetic Retinopathy
Longitudinal Observational Study of Diabetic Retinopathy Progression in Type 2 Diabetes Patients
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
Analysis of DR Progression to Identify Risks and Need for Treatment
Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression
Preparation of Patient Autologous Induced Pluripotent Stem Cell-derived Retinal Cells for AMD
AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Investigating the Retardation Effect of OCTA-Guided Targeted Photocoagulation on the Progression of Non-Perfusion Areas in Diabetic Retinopathy Patients
Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
Performance of the Electroretinogram, Performed and Interpreted by an Advanced Practice Nurse, in the Screening for Diabetic Retinopathy.
Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study
Retinal Investigation Using Optos OCT Device
An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Effect of Video Viewing on Intravitreal Injection Experience
The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma
Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy
Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
Visual Frailty in Ageing
Adjunct Episcleral Brachytherapy for PCV
AI-Powered DIY Screening System for Diabetic Retinopathy
Personalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus
Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy
Prospective Cohort Study on Predicting the Progression of Diabetic Microangiopathy Using Multimodal Eye Imaging
Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic Retinopathy
Defining Retinal Structures Using Hyperspectral Retinal Imaging
A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.
Is Community Based Monitoring of Diabetic Maculopathy and Pre-proliferative Diabetic Retinopathy Safe?
Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies
Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening
Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic Retinopathy
Evaluation of Clinical Progression, Prognostic Factors, and Quality of Life in Patients with Age-related Macular Degeneration.
Glaucoma Algorithm Validation Study in African Population - the MAGIC Study
Artificial Intelligence for Diagnosing Diabetic Retinopathy in Primary Care
Personalized Shared Eye-care Identification of Age-related Macular Degeneration Using Artificial Intelligence and Telemedicine by Matching Optometrist Office-based Sites With Clinical Supervision
Single-Cell Insights Into Diabetic Retinopathy Mechanisms
Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy
Comparing Artificial Intelligence for Assisted Diagnosis of Diabetic Retinopathy
Exploring the Interaction Between Metabolic Disorders and NLPR3 Inflammasome Activation in DR Inflammatory Damage
Retina clinical trials — common questions
Are retina clinical trials free to join?
Yes. Participating in a retina clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a retina clinical trial?
Each retina study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a retina trial near me?
Use the location controls above. We'll show recruiting retina trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many retina trials are recruiting right now?
We're currently tracking roughly 41 recruiting retina trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.